Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen clinical trial (NCT01204762). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from pegylated interferon lambda?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen clinical trial (NCT01204762). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen clinical trial (NCT01204762). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen clinical trial (NCT01204762). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any travel requirements for attending study visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen clinical trial (NCT01204762). Contact the study team or your healthcare provider for specific answers.

Question 6

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen clinical trial (NCT01204762). Contact the study team or your healthcare provider for specific answers.

What this study is about